Molecular strain typing by restriction fragment length polymorphism analysis was used to demonstrate that two clusters ofMycobacterium tuberculosis cultures involving six patients resulted from cross-contamination in the mycobacteriology laboratory. Contaminated cultures were processed by the decontamination procedure and were read on the BACTEC instrument following acid-fast bacillus smear-positive specimens from patients with active tuberculosis. Investigation of these episodes suggested opportunities for modification of laboratory procedures to minimize cross-contamination and confirmed the adverse medical and public health consequences of false-positive cultures. Strain-typing results were used in decisions regarding patient care, including the curtailment of unnecessary treatment in one patient. Molecular strain typing appears to be a valuable means of identifying false-positive cultures of M. tuberculosis in selected settings.
After decades of steady decline, there has been a dramatic resurgence of tuberculosis in the United States (3, 21) . This has resulted in an increase in the number of specimens being processed for mycobacterial culture by clinical laboratories, many of which have limited or diminishing resources. Even transient increases in the volume of testing may overload the capabilities of some facilities, thereby enhancing the likelihood of procedural lapses or equipment malfunction. As more positive specimens are processed there also will be an increased opportunity for the carryover of organisms from positive to negative specimens during batch processing of samples. Episodes of cross-contamination involving conventional (1, (13) (14) (15) and radiometric (4, 16, 26, 27) methodologies have been reported previously and may occur more frequently in the current environment.
Laboratory cross-contamination has been detected retrospectively in patients whose cultures yield Mycobacterium tuberculosis in the absence of signs or symptoms of tuberculosis and who subsequently have good clinical outcomes without therapy. When these criteria were applied in a recent investigation of a hospital-based outbreak involving multidrug-resistant M. tuberculosis, positive cultures for 16% of the 140 patients evaluated were considered to be the result of laboratory contamination (7) . This suggests that false-positive cultures may be common in some settings. However, the retrospective recognition of cross-contamination is of little help in the acute management of individual patients. The prospective recognition of false-positive cultures by clinicians is likely to become more problematic as the population of patients who are at risk for M. tuberculosis infection increases. The diagnosis of tuberculosis can be particularly complicated in patients who are also infected with human immunodeficiency virus, in whom the presentation of tuberculosis is highly variable (2) .
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We report the use of molecular strain typing by restriction fragment length polymorphism (RFLP) analysis to confirm our suspicion that cross-contamination had occurred in our mycobacteriology laboratory. RFLP analysis is a DNA fingerprinting technique that has been used to distinguish strains of many species of bacteria. The RFLP procedure used in the study described here makes use of a repetitive sequence of DNA, IS6110, which is found in the genomes of virtually all strains of M. tuberculosis (10) . Differences in the number and location of IS6110 within a strain's chromosomal DNA are revealed by RFLP analysis, which yields strain-specific patterns. There appears to be a sufficient diversity of patterns to ensure that epidemiologically unrelated strains have different RFLP patterns, whereas related strains have identical RFLP patterns (25) . These were reviewed by one of us (P.M.S.), and in selected cases, the treating physicians were interviewed to determine how the false-positive culture results were integrated into the care of these patients. For those patients with false-positive cultures, evidence of unnecessary resource utilization, therapy, and toxicity was sought. In addition, the physician's willingness to disregard these cultures on the basis of (i) the suspicion of laboratory cross-contamination and (ii) the RFLP documentation of cross-contamination was recorded. County public health tuberculosis control officers were also interviewed to determine the extent of follow-up undertaken for the patients with false-positive cultures.
RESULTS
The RFLP patterns of isolates sequentially processed by the laboratory (Fig. 1 ) demonstrate that positive cultures recovered before or after each cluster had unique RFLP patterns characteristic of different strains ofM. tuberculosis. In contrast, isolates suspected of being false positive because they closely followed the smear-positive samples in order of processing and reading on the BACTEC system had the same RFLP fingerprints as the isolates from the respective smear-positive index cases. No epidemiologic relationship between patients was detected either within or outside of the hospital setting. In addition, no evidence of contamination by equipment (such as bronchoscopes) outside of the laboratory could be found, and the false-positive cultures originated from a variety of specimen types. These epidemiologic considerations, together with the clinical information that made the diagnosis of active tuberculosis unlikely, supported the hypothesis that each cluster of positive cultures consisted of one true-positive culture from a patient with active tuberculosis whose strain had contaminated other cultures in the laboratory.
When positive cultures were reported, physicians were made aware that isolation of M. tuberculosis from each of the six patients believed to have a false-positive culture could be the result of laboratory cross-contamination. The lack of clinical evidence suggestive of active tuberculosis in three of these patients led to the immediate dismissal of the positive culture result. The false-positive results prompted additional physician consultation or clinic visits and the submission of additional specimens by three patients for microbiologic evaluation. One patient received 2 weeks of therapy for tuberculosis before the result was accepted as spurious. The existence of unrelated pulmonary disease complicated the differential diagnosis in two patients in whom the possibility of tuberculosis could not be excluded, and they were begun on antituberculosis therapy. In one of these patients, treatment was discontinued when RFLP results became available. However, the other patient completed 1 year of antimicrobial therapy. Both patients who received prolonged antimicrobial therapy suffered drug toxicity requiring alterations in their treatment regimens.
Public health officials also were informed of suspicions that cultures of M. tuberculosis from these patients might be false-positive results. Nonetheless, at least limited follow-up of most patients was undertaken; this consisted of consultation with physicians, inquiries regarding the patients' subsequent symptoms, and in some cases, skin testing of close contacts. Because of contact between one of the patients and residents of a homeless shelter, some of the occupants of the shelter received skin testing, chest X rays, and isoniazid prophylaxis. It is very difficult to determine the precise financial impact of these false-positive cultures. We estimate that the cost of additional testing, treatment, physician consultation, public health follow-up, and laboratory time that resulted from our series of false-positive cultures was approximately $15,000.
DISCUSSION
The isolation of even a single positive culture for M. tuberculosis could be the basis of a presumptive diagnosis of tuberculosis. A false-positive culture may have profound consequences on the clinical management of the patient. In our experience, the impact of false-positive cultures was significant, even though it was mitigated by early recognition that these were probably the result of laboratory crosscontamination. Patients with false-positive cultures were nonetheless subjected to additional physician consultations, radiographic studies, and acquisition of samples for culture. Another disturbing consequence of these spurious results was the unnecessary administration of antimicrobial therapy to patients and contacts, resulting in adverse drug reactions in two patients who were unnecessarily treated. In some cases there was extensive public health follow-up of contacts.
Cross-contamination in the mycobacteriology laboratory has been previously demonstrated on the basis of unusual antimicrobial susceptibility patterns (1, 15), unique biochemical characteristics (20) , and phage typing (11, 14) . However, most strains of M. tuberculosis have the same biochemical and drug susceptibility phenotypes. The high incidence of multidrug-resistant strains in certain hospitals (19) also limits the utility of susceptibility profiles for identifying clusters on the basis of unusual antimicrobial susceptibility patterns. Phage typing has been used successfully (11) to confirm instances of laboratory cross-contamination by the Centers for Disease Control and Prevention (CDC), Atlanta, Ga. However, this service is no longer offered by the CDC.
In contrast to these strain-typing techniques, the RFLP method used in the present study can be used for all isolates of M. tuberculosis, has an excellent ability to discriminate between strains (25), and can be completed within days after mycobacterial colonies are present on the solid media. In the investigation reported here, RFLP fingerprint analysis of M. tuberculosis isolates provided persuasive additional evidence that two clusters of positive cultures were due to cross-contamination of the samples in the laboratory.
Outbreaks involving the transmission of tuberculosis have occurred in hospitals, prisons, and homeless shelters (6) . In such a context, when true culture positivity rates are high, false-positive cultures also may have a higher probability of occurring, but they may be difficult to detect on the basis of either laboratory or clinical criteria. The possibility of transmission of a common strain or strains in such settings will reduce the power of RFLP or other strain-typing techniques to ascertain whether an outbreak of infections has occurred or whether positive cultures have resulted from cross-contamination in the laboratory. In such settings, the results of RFLP analysis must be interpreted in light of the relevant clinical and epidemiologic information.
Although the exact cause(s) of cross-contamination in our laboratory was not identified, investigation suggested that it resulted from the carryover of organisms from one sample to another during the decontamination procedure or during reading on the BACTEC system. False-positive results for mycobacteria have been reported to result from specimen mix-up (1), contamination of specimens or reagents with environmental mycobacteria in water (5, 8, 9, 23) (13, 14, 20) . Other laboratories have also described false-positive results associated with the use of the BACTEC 460 instrument. Because this instrument uses the same needle to sample multiple specimens, cross-contamination may be attributable to the transfer of inoculum from one culture to the next, perhaps because of the sporadic failure of the needle heater, circuit board, or other problems (4, 16, 26, 27) . Although diagnostic tests performed on-site by the manufacturer did not reveal a malfunction, the BACTEC 460 instrument was returned for refurbishing after the second contamination episode and a device for periodic monitoring of needle temperature was provided.
In response to our assessment that cross-contamination may have occurred either during the initial decontamination process or during the repetitive sampling of sequential vials by the BACIEC 460 system, procedures for processing of specimens for mycobacterial culture were reviewed and modified in order to decrease opportunities for the transfer of organisms from one specimen to another. The following procedures may prevent cross-contamination among AFB cultures and enable recognition of false-positive cultures should they occur.
(Additional procedures are required to avoid specimen mix-up, false-positive AFB smears (5, 22) , or contamination of specimens [9] or reagents [8, 23] with mycobacteria that are often found in water.) Decontamination procedure. Isolate each specimen completely so that there are no opportunities to transfer an inoculum from one sample to another via pipets, the lips or caps of tubes, splashes, or common reservoirs of reagents or containers used for discarded materials.
(i) When using pipets to deliver reagents, use a separate pipet for each specimen and each time that the reagent bottle is entered.
(ii) Predivide into aliquots reagents such as phosphate buffer which are used in volumes that are awkward to transfer via a pipet into individual sterile tubes. Use a separate tube to add reagents to each sample rather than dispensing them from a common container.
(iii) Remove and replace the cap from each specimen tube sequentially during the addition of specimens and reagents, so that only one tube is open at a time and so that tube caps do not become interchanged.
(iv) After centrifugation, pour off the supernatant from each specimen into a separate disposable discard tube instead of using a common discard container.
(v) Ensure that written procedures for the processing of cultures include detailed instructions for problem-prone steps and that staff have a very good understanding of the rationale for all aspects of the procedure.
BACTEC cultures. Ensure that equipment is properly maintained and monitored, avoid contamination of vial tops, and isolate positive cultures from other samples.
(i) Adhere strictly to the manufacturer's recommendations for maintenance and quality control (18) (iii) Track positivity rates prospectively and establish thresholds which provoke investigation when these thresh-olds are exceeded (for example, when the number of positive cultures exceeds the usual positivity rates or when isolates that are of an infrequently encountered species or that have an unusual resistance pattern are recovered sequentially or more frequently than usual).
(iv) Communicate with physicians and public health authorities when laboratory evidence of false-positive cultures is found and encourage them to notify the laboratory of results which appear to be inconsistent with clinical findings.
(v) If epidemiologic information demonstrates that it is unlikely that patients could be infected by the same strain, suspected false-positive as well as control isolates may be submitted to reference laboratories (through the CDC) for strain typing.
These procedures are intended to allow for the isolation of specimens so that there is no opportunity to transfer an inoculum between samples and to ensure that equipment is properly maintained and monitored. The techniques used by individuals who process specimens also may affect contamination rates (1) . Therefore, it is crucial that staff be well trained in these procedures and have a thorough understanding of the rationale for all procedural steps. Since the procedures described above were adopted and the BACTEC instrument was refurbished, no instances of cross-contamination have been identified in our laboratory during the subsequent 15 months. The marginal cost of implementing these additional measures resulted in an increase of approximately $0.75 for supplies and 1 to 3 min of technician time for each AFB culture done in our laboratory. This cost is minor compared with the resources that may be consumed as a result of false-positive cultures.
This report demonstrates the utility of a rapid molecular strain-typing method for M. tuberculosis for identifying problematic laboratory procedures and altering clinical care. There is no indication for fingerprinting of strains of M. tuberculosis or other mycobacteria on a routine basis; however, the ultimate role of such procedures in clinical laboratory practice for quality control purposes remains to be determined. Currently, strain-typing analysis is expensive and time-consuming and can be performed only by CDC and a few reference laboratories. However, the benefits of rapidly recognizing false-positive cultures of M. tuberculosis may justify the use of strain typing in selected situations.
